Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Results from a horizon scan on risks associated with transplantation of human organs, tissues and cells: from donor to patient.

Herberts CA, Park MV, Pot JW, de Vries CG.

Cell Tissue Bank. 2015 Mar;16(1):1-17. doi: 10.1007/s10561-014-9450-0. Epub 2014 May 1. Review.

PMID:
24789705
2.

Risk factors in the development of stem cell therapy.

Herberts CA, Kwa MS, Hermsen HP.

J Transl Med. 2011 Mar 22;9:29. doi: 10.1186/1479-5876-9-29.

3.

Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy.

Reits EA, Hodge JW, Herberts CA, Groothuis TA, Chakraborty M, Wansley EK, Camphausen K, Luiten RM, de Ru AH, Neijssen J, Griekspoor A, Mesman E, Verreck FA, Spits H, Schlom J, van Veelen P, Neefjes JJ.

J Exp Med. 2006 May 15;203(5):1259-71. Epub 2006 Apr 24.

4.

Cutting edge: HLA-B27 acquires many N-terminal dibasic peptides: coupling cytosolic peptide stability to antigen presentation.

Herberts CA, Neijssen JJ, de Haan J, Janssen L, Drijfhout JW, Reits EA, Neefjes JJ.

J Immunol. 2006 Mar 1;176(5):2697-701.

5.

MHC class I alleles and their exploration of the antigen-processing machinery.

Groothuis TA, Griekspoor AC, Neijssen JJ, Herberts CA, Neefjes JJ.

Immunol Rev. 2005 Oct;207:60-76. Review.

PMID:
16181327
6.

Vigorous but short-term gamma interferon T-cell responses against a dominant HLA-A*02-restricted measles virus epitope in patients with measles.

Jaye A, Herberts CA, Jallow S, Atabani S, Klein MR, Hoogerhout P, Kidd M, van Els CA, Whittle HC.

J Virol. 2003 Apr;77(8):5014-6.

7.

Autoreactivity against induced or upregulated abundant self-peptides in HLA-A*0201 following measles virus infection.

Herberts CA, van Gaans-van den Brink J, van der Heeft E, van Wijk M, Hoekman J, Jaye A, Poelen MC, Boog CJ, Roholl PJ, Whittle H, de Jong AP, van Els CA.

Hum Immunol. 2003 Jan;64(1):44-55.

PMID:
12507814
8.

Dynamics of measles virus protein expression are reflected in the MHC class I epitope display.

Herberts CA, Meiring HM, van Gaans-van den Brink JA, van der Heeft E, Poelen MC, Boog CJ, de Jong AP, van Els CA.

Mol Immunol. 2003 Jan;39(10):567-75.

PMID:
12431390
9.

A measles virus glycoprotein-derived human CTL epitope is abundantly presented via the proteasomal-dependent MHC class I processing pathway.

Herberts CA, Stittelaar KJ, van der Heeft E, van Gaans-Van den Brink J, Poelen MC, Roholl PJ, van Alphen LJ, Melief CJ, de Jong AP, van Els CA.

J Gen Virol. 2001 Sep;82(Pt 9):2131-42.

PMID:
11514722
10.

A single naturally processed measles virus peptide fully dominates the HLA-A*0201-associated peptide display and is mutated at its anchor position in persistent viral strains.

van Els CA, Herberts CA, van der Heeft E, Poelen MC, van Gaans-van den Brink JA, van der Kooi A, Hoogerhout P, Jan ten Hove G, Meiring HD, de Jong AP.

Eur J Immunol. 2000 Apr;30(4):1172-81.

11.

A microcapillary column switching HPLC-electrospray ionization MS system for the direct identification of peptides presented by major histocompatibility complex class I molecules.

van der Heeft E, ten Hove GJ, Herberts CA, Meiring HD, van Els CA, de Jong AP.

Anal Chem. 1998 Sep 15;70(18):3742-51.

PMID:
9751018
12.

Development of methionine synthase, cystathionine-beta-synthase and S-adenosyl-homocysteine hydrolase during gestation in rats.

VanAerts LA, Poirot CM, Herberts CA, Blom HJ, De Abreu RA, Trijbels JM, Eskes TK, Peereboom-Stegeman JH, Noordhoek J.

J Reprod Fertil. 1995 Mar;103(2):227-32.

PMID:
7616494

Supplemental Content

Loading ...
Support Center